Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype Reply

M.P. Schlaich, C. Borghi, M. Tomaszewski, G.S. Stergiou, A.E. Schutte, T. Unger*, 2020 ISH Global Hypertension Practice Guidelines Committee

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)2339-2340
Number of pages2
JournalJournal of Hypertension
Issue number11
Publication statusPublished - 1 Nov 2020


  • disorder

Cite this